Drug-eluting stent update 2007: part III: Technique and unapproved/unsettled indications (left main, bifurcations, chronic total occlusions, small vessels and long lesions, saphenous vein grafts, acute myocardial infarctions, and multivessel disease).
Colombo
Antonio
A
San Raffaele Scientific Institute and EMO Centro Cuore Columbus, 20145 Milan, Italy. info@emocolumbus.it
Chieffo
Alaide
A
D015906:Angioplasty, Balloon, Coronary; D002317:Cardiovascular Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000145:classification / Q000188:drug therapy* / Q000601:surgery / Q000628:therapy; D023903:Coronary Restenosis / Q000517:prevention & control*; D004343:Drug Implants; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy / Q000628:therapy; D017239:Paclitaxel / Q000008:administration & dosage / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D012501:Saphenous Vein / Q000637:transplantation; D020123:Sirolimus / Q000008:administration & dosage / Q000627:therapeutic use*; D015607:Stents; D016896:Treatment Outcome
D002317:Cardiovascular Agents; D004343:Drug Implants; D017239:Paclitaxel; D020123:Sirolimus